Palvella Therapeutics (PVLA) Preferred Dividend Payments (2024)
Palvella Therapeutics (PVLA) reported Preferred Dividend Payments of -$582000.0 for Q4 2024, down 400.0% quarter-over-quarter from $194000.0 in Q3 2024.
Palvella Therapeutics (PVLA) Preferred Dividend Payments (2024) Analysis & Trends
Palvella Therapeutics (PVLA) has 1 years of Preferred Dividend Payments data on file, last reported at -$582000.0 in Q4 2024.
- Preferred Dividend Payments for Q4 2024 came in at -$582000.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2025 was -$582000.0 (changed N/A YoY), and the FY2023 annual result was $776000.0, changed N/A from the prior year.
- Preferred Dividend Payments fell to -$582000.0 in Q4 2024 per PVLA's latest filing, from $194000.0 in the prior quarter.
- Over five years, Preferred Dividend Payments peaked at $194000.0 in Q1 2024 and troughed at -$582000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Palvella Therapeutics | 1.49 Bn | 1.23 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -582,000.00 |
| Sep 30, 2024 | 194,000.00 |
| Jun 30, 2024 | 194,000.00 |
| Mar 31, 2024 | 194,000.00 |